Inovio Pharmaceuticals, Inc. · NASDAQ:INO

Shea Jacqueline Elizabeth exercised options for 17,744 Inovio Pharmaceuticals, Inc. shares (Form 4)

Traded May 15, 2026 · Filed May 18, 2026

On May 15, 2026, Shea Jacqueline Elizabeth (Director, Chief Executive Officer) exercised options for 17,744 Inovio Pharmaceuticals, Inc. shares, leaving 95,031 shares. Filed May 18, 2026 (Form 4).

Options exercised
17,744 shares
Holding after
95,031 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 15, 2026Common StockOption exercise17,744102,748Direct
May 15, 2026Common StockShares withheld for tax7,717US$1.3095,031Direct

Source

View original at SEC

Related